The list of funded grants associated with members of COST Action CA20121 (BenBedPhar) illustrates the remarkable diversity and collaborative strength of the network. These projects span a wide range of scientific fields, from molecular pharmacology and redox biology to translational medicine and disease prevention, yet they share a unifying scientific focus on the NRF2 pathway.

NRF2 is a key transcription factor regulating cellular defense mechanisms against oxidative stress and inflammation, and its modulation has become a central theme connecting these initiatives. Across different grants, researchers investigate the role of NRF2 in metabolic disorders, neurodegeneration, cancer, cardiovascular diseases, and pharmacological protection, reflecting the broad translational relevance of this pathway.

The successful acquisition of these competitive grants was made possible thanks to the synergies, interactions, and knowledge exchange fostered through the BenBedPhar COST Action. The networking tools provided by COST, including workshops, short-term scientific missions, and training schools, have been instrumental in building interdisciplinary collaborations, enabling researchers to generate preliminary data, refine hypotheses, and develop joint proposals.

Together, these outcomes demonstrate how COST Action CA20121 serves as a catalyst for innovation, transforming cooperation into concrete research funding, and advancing the scientific understanding and therapeutic potential of NRF2 signaling across Europe and beyond.